Aclidinium bromide/formoterol

Aclidinium bromide/formoterol
Combination of
Aclidinium bromide	Long-acting muscarinic antagonist
Formoterol	Long-acting β2 agonist
Clinical data
Trade names	Brimica Genuair, Duaklir Genuair, Duaklir Pressair
AHFS/Drugs.com	Professional Drug Facts
License data	US DailyMed: Duaklir;
Pregnancy; category	AU: B3;
Routes of; administration	Inhalation
ATC code	R03AL05 (WHO) ;
Legal status
Legal status	AU: S4 (Prescription only) ; UK: POM (Prescription only) [1]; US: ℞-only [2]; EU: Rx-only [3][4]; In general: ℞ (Prescription only);
Identifiers
CAS Number	2446159-07-3;
KEGG	D11857;

Aclidinium bromide/formoterol, sold under the brand names Duaklir and Brimica, is a fixed-dose combination medication for inhalation, used in the management of chronic obstructive pulmonary disease (COPD).[5] It consists of aclidinium bromide, a long-acting muscarinic antagonist, and formoterol, a long-acting β₂ agonist.[3][4]

References

"Duaklir Genuair 340 micrograms /12 micrograms inhalation powder - Summary of Product Characteristics (SmPC)". (emc). 9 September 2019. Retrieved 26 July 2020.
"Duaklir Pressair- aclidinium bromide and formoterol fumarte powder, metered". DailyMed. 3 July 2020. Retrieved 28 November 2020.
"Duaklir Genuair EPAR". European Medicines Agency (EMA). Retrieved 26 July 2020.
"Brimica Genuair EPAR". European Medicines Agency (EMA). Retrieved 26 July 2020.
D'Urzo AD, Singh D, Donohue JF, Chapman KR, Wise RA (September 2021). "Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update". Expert Review of Respiratory Medicine. 15 (9): 1093–1106. doi:10.1080/17476348.2021.1920403. PMID 34137664.

"Aclidinium bromide". Drug Information Portal. U.S. National Library of Medicine.
"Formoterol fumarate". Drug Information Portal. U.S. National Library of Medicine.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.